Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer's & chronic kidney disease.
Price: $1.57 Volume: 33,890
Change: +$0.07 % Change: +4.67%
Day High/Low: 1.60/1.52 52 Week High/Low: 3.13/0.405
Last Traded: August 28, 2015 11:59 Transaction Volume: 300
Open: 1.55 Previous Close: 1.50
Bid: 1.55 Ask: 1.60
Bid Size: 3100 Ask Size: 8200
Market Cap: 165.0m Shares Out: 105.1m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts